Literature DB >> 17005349

MR contrast agents, the old and the new.

Marie-France Bellin1.   

Abstract

Magnetic resonance (MR) contrast agents are increasingly being used to help detect and characterize various neoplastic, inflammatory and functional abnormalities. The extracellular, non-specific contrast agents gadolinium chelates are by far the most widely used. Over the past few years a number of MR organ specific contrast agents have been introduced. MRI contrast agents are generally safe and well tolerated. The present review summarizes the properties, main characteristics and imaging applications of commercially available compounds as well as safety of these agents in normal and high-risk patients.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17005349     DOI: 10.1016/j.ejrad.2006.06.021

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  46 in total

1.  Gadolinium compounds signaling through TLR4 and TLR7 in normal human macrophages: establishment of a proinflammatory phenotype and implications for the pathogenesis of nephrogenic systemic fibrosis.

Authors:  Peter J Wermuth; Sergio A Jimenez
Journal:  J Immunol       Date:  2012-05-30       Impact factor: 5.422

Review 2.  Macromolecules, dendrimers, and nanomaterials in magnetic resonance imaging: the interplay between size, function, and pharmacokinetics.

Authors:  Aaron Joseph L Villaraza; Ambika Bumb; Martin W Brechbiel
Journal:  Chem Rev       Date:  2010-05-12       Impact factor: 60.622

3.  Improved quantification of myocardial blood flow using highly constrained back projection reconstruction.

Authors:  David Chen; Behzad Sharif; Rohan Dharmakumar; Louise E J Thomson; C Noel Bairey Merz; Daniel S Berman; Debiao Li
Journal:  Magn Reson Med       Date:  2013-10-01       Impact factor: 4.668

Review 4.  Clinically Approved Nanoparticle Imaging Agents.

Authors:  Avnesh S Thakor; Jesse V Jokerst; Pejman Ghanouni; Jos L Campbell; Erik Mittra; Sanjiv S Gambhir
Journal:  J Nucl Med       Date:  2016-10-13       Impact factor: 10.057

5.  In Vivo Molecular Characterization of Abdominal Aortic Aneurysms Using Fibrin-Specific Magnetic Resonance Imaging.

Authors:  René M Botnar; Julia Brangsch; Carolin Reimann; Christian H P Janssen; Reza Razavi; Bernd Hamm; Marcus R Makowski
Journal:  J Am Heart Assoc       Date:  2018-05-30       Impact factor: 5.501

Review 6.  Imaging of liver cancer.

Authors:  Ben Ariff; Claire R Lloyd; Sameer Khan; Mohamed Shariff; Andrew V Thillainayagam; Devinder S Bansi; Shahid A Khan; Simon D Taylor-Robinson; Adrian K P Lim
Journal:  World J Gastroenterol       Date:  2009-03-21       Impact factor: 5.742

7.  (89)Zr-labeled paramagnetic octreotide-liposomes for PET-MR imaging of cancer.

Authors:  Diane S Abou; Daniel L J Thorek; Nicholas N Ramos; Martijn W H Pinkse; Hubert T Wolterbeek; Sean D Carlin; Bradley J Beattie; Jason S Lewis
Journal:  Pharm Res       Date:  2012-12-07       Impact factor: 4.200

8.  Gadolinium-conjugated dendrimer nanoclusters as a tumor-targeted T1 magnetic resonance imaging contrast agent.

Authors:  Zhiliang Cheng; Daniel L J Thorek; Andrew Tsourkas
Journal:  Angew Chem Int Ed Engl       Date:  2010       Impact factor: 15.336

Review 9.  Paramagnetic liposome nanoparticles for cellular and tumour imaging.

Authors:  Nazila Kamaly; Andrew D Miller
Journal:  Int J Mol Sci       Date:  2010-04-15       Impact factor: 5.923

10.  Strategies for Target-Specific Contrast Agents for Magnetic Resonance Imaging.

Authors:  Sashiprabha M Vithanarachchi; Matthew J Allen
Journal:  Curr Mol Imaging       Date:  2012-10-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.